logo

JANX

Janux Therapeutics·NASDAQ
--
--(--)
--
--(--)

JANX fundamentals

Janux Therapeutics (JANX) released its earnings on Aug 7, 2025: revenue was 0 (YoY -100.00%), missed estimates; EPS was -0.55 (YoY -400.00%), missed estimates.
Revenue / YoY
0
-100.00%
EPS / YoY
-0.55
-400.00%
Report date
Aug 7, 2025
EPS
Q2,2021
Q3,2021
Q4,2021
Q1,2022
Q2,2022
Q3,2022
Q4,2022
Q1,2023
Q2,2023
Q3,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Actual
-0.62-0.26-0.33-0.32-0.41-0.4-0.39-0.42-0.42-0.25-0.25-0.3-0.11-0.51-0.36-0.38-0.55
Forecast
-0.14-0.1767-0.27-0.32-0.3167-0.4675-0.4812-0.486-0.502-0.47-0.4152-0.3313-0.3107-0.3273-0.4607-0.3821-0.4723
Surprise
-342.86%
-47.14%
-22.22%
0.00%
-29.46%
+14.44%
+18.95%
+13.58%
+16.33%
+46.81%
+39.79%
+9.45%
+64.60%
-55.82%
+21.86%
+0.55%
-16.45%
Revenue
Q2,2021
Q3,2021
Q4,2021
Q1,2022
Q2,2022
Q3,2022
Q4,2022
Q1,2023
Q2,2023
Q3,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Actual
491.00K1.16M1.62M1.59M2.38M1.81M2.85M2.05M1.06M2.52M2.46M1.25M8.90M439.00K000
Forecast
133.33K133.33K433.33K810.40K650.00K742.58K805.50K672.35K875.00K845.50K750.00K878.57K772.00K1.50M409.92K590.91K272.73K
Surprise
+268.25%
+769.25%
+272.92%
+96.75%
+266.54%
+144.15%
+253.20%
+204.60%
+20.80%
+197.69%
+228.13%
+42.50%
+1052.46%
-70.64%
-100.00%
-100.00%
-100.00%

Earnings Call